Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Thalidomide clinical trials in brain cancer expanded

Nov. 21, 1996

Angiogenesis-inhibitory activity reported for spironolactone

Nov. 21, 1996

Ansan starts new development program for chemotherapy-induced alopecia

Nov. 20, 1996

Sanofi introduces new platinum complex

Nov. 20, 1996

Tanabe to develop marimastat

Nov. 20, 1996

Johns Hopkins University reports antiproliferative vitamin D3 analogue

Nov. 20, 1996

400-C, new FPTase inhibitor reported by Schering-Plough

Nov. 20, 1996

FPTase inhibitior series reported by Schering-Plough

Nov. 20, 1996

Fujisawa describes new agents for thrombocytopenia

Nov. 20, 1996

New farnesyl protein transferase series synthesized at Merck & Co.

Nov. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...